Sarah Gregg, LCSW | |
1960 Nw 167th Pl Ste 100, Beaverton, OR 97006-4805 | |
(503) 672-6007 | |
(503) 672-6001 |
Full Name | Sarah Gregg |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 17 Years |
Location | 1960 Nw 167th Pl Ste 100, Beaverton, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740637164 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | L6098 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Legacy Good Samaritan Medical Center | Portland, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Legacy Good Samaritan Hospital And Medical Center | 0547179939 | 128 |
News Archive
GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.
HHS Secretary Kathleen Sebelius will announce one of the first steps the Department is taking to implement the temporary high risk pool program called for in the new health reform law on a conference call with reporters at 12:30 p.m. EDT.
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.
Scientists at The University of Nottingham and the Wellcome Trust Sanger Institute near Cambridge have pin-pointed the 72 molecular switches that control the three key stages in the life cycle of the malaria parasite and have discovered that over a third of these switches can be disrupted in some way.
Critical Path Institute (C-Path) announced today that its Type 1 Diabetes (T1D) Consortium has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the FDA's decision to accept the consortium's Biomarker Initiative project into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
› Verified 2 days ago
Entity Name | Legacy Good Samaritan Hospital And Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780608216 PECOS PAC ID: 0547179939 Enrollment ID: O20031125000416 |
News Archive
GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.
HHS Secretary Kathleen Sebelius will announce one of the first steps the Department is taking to implement the temporary high risk pool program called for in the new health reform law on a conference call with reporters at 12:30 p.m. EDT.
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.
Scientists at The University of Nottingham and the Wellcome Trust Sanger Institute near Cambridge have pin-pointed the 72 molecular switches that control the three key stages in the life cycle of the malaria parasite and have discovered that over a third of these switches can be disrupted in some way.
Critical Path Institute (C-Path) announced today that its Type 1 Diabetes (T1D) Consortium has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the FDA's decision to accept the consortium's Biomarker Initiative project into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah Gregg, LCSW 1960 Nw 167th Pl Ste 100, Beaverton, OR 97006-4805 Ph: (503) 672-6007 | Sarah Gregg, LCSW 1960 Nw 167th Pl Ste 100, Beaverton, OR 97006-4805 Ph: (503) 672-6007 |
News Archive
GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.
HHS Secretary Kathleen Sebelius will announce one of the first steps the Department is taking to implement the temporary high risk pool program called for in the new health reform law on a conference call with reporters at 12:30 p.m. EDT.
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.
Scientists at The University of Nottingham and the Wellcome Trust Sanger Institute near Cambridge have pin-pointed the 72 molecular switches that control the three key stages in the life cycle of the malaria parasite and have discovered that over a third of these switches can be disrupted in some way.
Critical Path Institute (C-Path) announced today that its Type 1 Diabetes (T1D) Consortium has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the FDA's decision to accept the consortium's Biomarker Initiative project into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
› Verified 2 days ago
Alan Hershman, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14255 Sw Brigadoon Ct Ste 80, Beaverton, OR 97005 Phone: 503-641-1475 | |
Carla E Fadriquela, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2980 Sw 123rd Ave, Beaverton, OR 97005 Phone: 808-281-4616 | |
Tiffanie B Galupi, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1925 Ne Stucki Ave, Beaverton, OR 97006 Phone: 503-906-5000 | |
Stephanie Anne Cox, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6900 Sw 105th Ave Ste B, Beaverton, OR 97008 Phone: 541-638-0830 | |
Ms. Aja Riley Bennett, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 15270 Sw Mallard Dr Ste 101, Beaverton, OR 97007 Phone: 214-454-1447 | |
Tucker Hardy, MSW, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10700 Sw Beaverton Hillsdale Hwy Ste 350, Beaverton, OR 97005 Phone: 971-279-2067 Fax: 971-302-6956 | |
Jessica Edit Villasenor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4537 Sw 96th Ave, Beaverton, OR 97005 Phone: 503-376-9520 |